Announced Thu, 13 Aug · 13:09 IST
Themis Medicare Q1 FY27: PAT turns positive on Rs 99.67 cr exceptional gain
Revenue DeclineEbitda Margin CompressionExceptional ItemPat Growth 25pctEmphasis Of MatterResults View source PDFExplain this filing
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹107.25
prior close
₹109.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.8-5.5-4.6-4.5-2.6-0.2-1.2-2.2-4.0+12.4+15.9+12.0——
Up moveDown movePending
AI summary
Themis Medicare Q1 FY27 (June 2026) standalone revenue fell 10.9% to Rs 869.57 cr from Rs 975.78 cr. Operating loss widened to Rs 569.45 cr from Rs 139.25 cr. A one-time exceptional gain of Rs 99.67 cr from sale of associate company shares (Gujarat Themis Biosyn) for Rs 100 cr swung PAT to a profit of Rs 287.37 cr versus a loss of Rs 153.74 cr last year. EPS was Rs 3.12 vs negative Rs 1.67. Auditor flagged Carpo Medicals strike-off as emphasis of matter.
Likely market impact
Core business weakened with revenue decline and wider operating loss; one-time share sale gain lifted headline profit. Watch sustainability of operations.